Targeting KRAS in lung cancer

preview_player
Показать описание
Jong Woo Lee, MD, PhD, Yale Cancer Center and Yale University School of Medicine, New Haven, CT, talks on targeting KRAS in lung cancer. Based on research, combining Aurora Kinase A (ARUKA) inhibition with WEE1 inhibition can potentiate the inhibition of KRAS in lung cancer. This interview took place at the IASLC 2022 World Conference on Lung Cancer congress in Vienna, Austria.
  1. VJOncology
  2. Speaker: Jong Woo Lee
  3. Institution: Yale Cancer Center and Yale University School of Medicine
  4. Event: WCLC 2022
  5. Format: Interview
  6. Subject: Lung Cancer
Рекомендации по теме
Targeting KRAS in 0:00:48

Targeting KRAS in lung cancer

KRYSTAL-1 and CodeBreak 0:01:26

KRYSTAL-1 and CodeBreak 100: targeting KRAS G12C in lung cancer

Challenges of KRAS-targeting 0:01:25

Challenges of KRAS-targeting for lung cancer therapy

Targeting KRAS: future 0:01:02

Targeting KRAS: future directions

Targeting KRAS mutations 0:02:26

Targeting KRAS mutations in lung cancer

Targeted Therapy for 0:07:23

Targeted Therapy for KRAS-Mutant NSCLC

Challenges of Targeted 0:04:04

Challenges of Targeted KRAS Treatment & Current Treatments - Targeted Therapies in Lung Cancer 2...

Targeting non-G12C KRAS 0:01:10

Targeting non-G12C KRAS mutations in NSCLC

KRAS G12C Inhibitors 0:03:56

KRAS G12C Inhibitors Versus Chemotherapy in Second Line - Targeted Therapies in Lung Cancer 2023

Targeting KRAS-driven NSCLC 0:00:49

Targeting KRAS-driven NSCLC

Development of KRAS 0:05:29

Development of KRAS G12C-Targeted Therapy in NSCLC

Targeted Therapy for 0:02:49

Targeted Therapy for KRAS p.G12C NSCLC

The potential of 0:10:34

The potential of KRAS inhibitors for non-small-cell lung cancer

Terri - How 0:01:34

Terri - How has your KRAS mutation affected the treatment options available to you?

KRAS G12C Emerges 0:00:50

KRAS G12C Emerges as New Potential Target in Non-Small Cell Lung Cancer

Recent advances in 0:01:22

Recent advances in targeted agents for the treatment of lung cancer

History of KRAS-targeting 0:03:20

History of KRAS-targeting in clinical trials

Challenges in targeting 0:01:09

Challenges in targeting KRASG12C mutations

Understanding NSCLC Treatment 0:04:43

Understanding NSCLC Treatment When You Have a KRAS Mutation

KRAS-Mutant NSCLC 0:07:00

KRAS-Mutant NSCLC

Advances in the 0:02:12

Advances in the management of KRAS-mutant NSCLC

Data on KRAS 0:00:35

Data on KRAS inhibitors in lung cancer at WCLC 2022

Treating KRAS G12C 0:01:42

Treating KRAS G12C Mutations

How do doctors 0:02:31

How do doctors treat lung cancer with KRAS mutations?